Azenta, Inc.

NasdaqGS AZTA

Azenta, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2024

Azenta, Inc. Revenue Per Share is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Azenta, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 10.05, a 35.51% change year over year.
Azenta, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 7.42, a -44.47% change year over year.
Azenta, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 13.36, a 9.50% change year over year.
Azenta, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 12.20, a 12.32% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

NasdaqGS: AZTA

Azenta, Inc.

CEO	Mr. John P. Marotta
IPO Date	Feb. 2, 1995
Location	United States
Headquarters	15 Elizabeth Drive
Employees	3,300
Sector	Healthcare
Industries Biotechnology Big Data Cleaning Supplies Clinical Trials Frozen Foods Non-Alcoholic Beverages Research & Consulting Warehousing

Description

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.

Key trends

Past 5 years